Galderma

Relfydess recieves for glabellar lines in China

Pharmaceutical company Galderma has announced that China’s National Medical Products Administration (NPA) has approved Relfydess (relabotulinumtoxinA) for the temporary improvement of moderate-to-severe glabellar lines in adults. The approval is supported

Read More »

Study explores menopausal skin treatments

Pharmaceutical company Galderma has released data that suggest the sequence of injectable treatments may influence skin-quality outcomes in menopausal women. An eight-month investigator-initiated trial, led by plastic surgeon Mr Andreas

Read More »

ALASTIN releases peptide complex

Skincare company ALASTIN from pharmaceutical company Galderma has reintroduced its Restorative Skin Complex with an updated formula. The company shares that the new formulation includes TriHex+ Technology, which is enhanced

Read More »

CCR announces educational conferences

The Clinical Cosmetic Regenerative Congress (CCR) will bring together a two-day educational programme spanning multiple stages and formats. Sessions will take place across The Innovation Forum, the Dentists in Aesthetic

Read More »

Galderma hosts Open Clinic

Pharmaceutical company Galderma welcomed press and specialty guests to a healthcare practitioner-led Open Clinic at The Londoner Hotel on June 30. Guests were invited to undergo a personalised skin analysis

Read More »